From: The emerging clinical relevance of genomic profiling in neuroendocrine tumours
Patient | Material | Site of Origin | WHO Classification |
---|---|---|---|
P1 | Liquid Biopsy | Foregut (Lung) | G1 |
P2 | Liquid Biopsy | Foregut (Pancreas) | G2 |
P3 | Liquid Biopsy | Foregut (Pancreas) | G3 |
P4 | FFPE tissue | Foregut (Thymus) | G1 |
P5 | FFPE tissue | Other (Surrenal cortical carcinoma, NET) | G3 |
P6 | FFPE tissue | Hindgut (Rectum) | G2 |
P7 | FFPE tissue | Foregut (Thyroid) | G1 |
P8 | FFPE tissue | Foregut (Pancreas) | G3 |
P9 | FFPE tissue | Other (Urinary system, NEC) | G3 |
P10 | Peripheral Blood | Foregut (Thyroid) | G1 |
P11 | Peripheral Blood | Foregut (Parathyroid) | G1 |
P12 | Peripheral Blood | Foregut (Thyroid) | G1 |
P13 | Peripheral Blood | Foregut (Pancreas) | G3 |
P14 | Peripheral Blood | Foregut (Stomach) | G2 |
P15 | Peripheral Blood | Other (Primary location unknown) | G3 |
P16 | Peripheral Blood | Foregut (Thyroid) | G1 |
P17 | Peripheral Blood | Foregut (Thyroid) | G1 |
P18 | Peripheral Blood | Foregut (Thyroid) | G2 |
P19 | Peripheral Blood | Foregut (Thyroid) | G1 |
P20 | Peripheral Blood | Hindgut (Rectum) | G3 |
P21 | Peripheral Blood | Foregut (Thyroid) | G1 |
P22 | Peripheral Blood | Foregut (Thyroid) | G2 |
P23 | Peripheral Blood | Foregut (Pancreas) | G3 |
P24 | Peripheral Blood | Foregut (Pancreas) | G2 |
P25 | Peripheral Blood | Foregut (Pancreas) | G1 |
P26 | Peripheral Blood | Foregut (Pancreas) | G1 |
P27 | Peripheral Blood | Foregut (Pancreas) + Hindgut (Rectum) | G3 |
P28 | Peripheral Blood | Foregut (Pancreas) | G3 |
P29 | Peripheral Blood | Foregut (Pancreas) | G1 |
P30 | Peripheral Blood | Other (Primary location unknown, Hepatic and Pancreas NET) | G3 |
P31 | Peripheral Blood | Foregut (Pancreas) | G1 |
P32 | Peripheral Blood | Foregut (Pancreas) | G3 |
P33 | Peripheral Blood | Foregut (Pancreas) | G1 |
P34 | Peripheral Blood | Other (Head and Neck NET) | G3 |
P35 | Peripheral Blood | Other (Paraganglioma, NET) | G2 |